KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Retained Earnings (2016 - 2025)

Regeneron Pharmaceuticals has reported Retained Earnings over the past 17 years, most recently at $77.5 million for Q4 2025.

  • Quarterly results put Retained Earnings at $77.5 million for Q4 2025, down 99.76% from a year ago — trailing twelve months through Dec 2025 was $77.5 million (down 99.76% YoY), and the annual figure for FY2025 was $77.5 million, down 99.76%.
  • Retained Earnings for Q4 2025 was $77.5 million at Regeneron Pharmaceuticals, down from $35.0 billion in the prior quarter.
  • Over the last five years, Retained Earnings for REGN hit a ceiling of $35.0 billion in Q3 2025 and a floor of -$223.8 million in Q2 2022.
  • Median Retained Earnings over the past 5 years was $20.5 billion (2021), compared with a mean of $15.9 billion.
  • Peak annual rise in Retained Earnings hit 232632.63% in 2022, while the deepest fall reached 1150.0% in 2022.
  • Regeneron Pharmaceuticals' Retained Earnings stood at $19.0 billion in 2021, then grew by 22.87% to $23.3 billion in 2022, then tumbled by 100.35% to -$80.9 million in 2023, then surged by 39250.68% to $31.7 billion in 2024, then tumbled by 99.76% to $77.5 million in 2025.
  • The last three reported values for Retained Earnings were $77.5 million (Q4 2025), $35.0 billion (Q3 2025), and $33.7 billion (Q2 2025) per Business Quant data.